DOE Isotope Program Highlights
NextGen power sources may satisfy the need for long-term, compact power for use in remote or extreme environments.
Promising study details how radioactive agents could be sent directly to cancer cells.
A high-speed, high-yield recovery approach for At-211 means improved availability of this cancer-treating isotope.
New production methods for Ce-134 advance technologies for imaging human disease and guiding treatment.
Julie Ezold, section head at ORNL, has been elected to a three-year term on the American Nuclear Society’s Board of Directors.
A new supply of a critical radioisotope advances personalized medicine.
New system makes it easier to produce isotopes for radiopharmaceutical therapy.
With less than 250 nanograms of the element, the team measured the first-ever einsteinium bond distance, a basic property of an element’s interactions with other atoms and molecules.
World Cancer Day is 2/4, a time to reckon with the disease that currently impacts more than a 1M Americans per year.
When Sandra Davern looks to the future, she sees isotopes sent into the body with a specific target: cancer cells.